ES414093A1 - Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria - Google Patents

Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria

Info

Publication number
ES414093A1
ES414093A1 ES414093A ES414093A ES414093A1 ES 414093 A1 ES414093 A1 ES 414093A1 ES 414093 A ES414093 A ES 414093A ES 414093 A ES414093 A ES 414093A ES 414093 A1 ES414093 A1 ES 414093A1
Authority
ES
Spain
Prior art keywords
translation
obtaining
pharmaceutical composition
weight
machine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES414093A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biorex Laboratories Ltd
Original Assignee
Biorex Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd
Publication of ES414093A1 publication Critical patent/ES414093A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedimiento para la obtención de una composición farmacéutica anti-inflamatoria , en forma de dosis unitaria, de peso entre 0,20 y 5, 0 g, preferentemente entren 0,7 y 2,6 g, caracterizado porque comprende las etapas de primeramente mezclar (a) 1-100 mg de ácido glicirretínico y /o al menos un derivado anti-inflamatorio activo del mismo y (b) 1-50% en peso de ácido algínico y/o al menos una sal no tóxica del mismo y/o al menos una carboxialquil-celulosa y/o al menos una sal no-tóxica de la misma; en una segunda etapa mezcla © 1-30% en peso de al menos un carbonato no-toxico y/o bicarbonato y (d) 0-30% en peso de al menos un compuesto antiácido, y en una última etapa hacer reaccionar las mezclas obtenidas en las primeras dos etapas.
ES414093A 1972-12-18 1973-04-26 Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria Expired ES414093A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5835472A GB1390683A (en) 1972-12-18 1972-12-18 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES414093A1 true ES414093A1 (es) 1981-08-16

Family

ID=10481401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES414093A Expired ES414093A1 (es) 1972-12-18 1973-04-26 Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria

Country Status (14)

Country Link
US (1) US3944660A (es)
BE (1) BE802700A (es)
CA (1) CA1006091A (es)
DE (1) DE2360918C3 (es)
ES (1) ES414093A1 (es)
FR (1) FR2210399B1 (es)
GB (1) GB1390683A (es)
HK (1) HK41078A (es)
IE (1) IE38520B1 (es)
IL (1) IL42313A (es)
KE (1) KE2853A (es)
MY (1) MY7800368A (es)
NL (1) NL164472C (es)
ZA (1) ZA732438B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
US4184888A (en) * 1978-03-01 1980-01-22 Dap Inc. Effervescent adhesive-forming product
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
ES8307096A1 (es) * 1981-06-01 1983-07-01 Orion Yhtymae Oy "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
EP0093520B1 (en) * 1982-04-27 1986-10-15 Noristan Limited Pharmaceutical compositions and preparation thereof
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions
EP0250572A1 (en) * 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
EP0484106A1 (en) * 1990-11-01 1992-05-06 Merck & Co. Inc. Controlled release formulations
DE102006037298A1 (de) * 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
ITMI20121916A1 (it) * 2012-11-09 2014-05-10 Velleja Res Srl Formulati a cessione intra-gastrica ritardata a base di derivati della glycyrrhiza glabra

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES296176A1 (es) 1964-02-06 1964-05-16 Ferrer Labor Un nuevo compuesto del acido glicirretinico de actividad medicamentosa y su procedimiento de fabricaciën
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3764618A (en) * 1970-10-27 1973-10-09 Dott Inverni & Della Beffa S P Aluminum salts of 3-acetyl-18{62 -glycyrrhetinic acid

Also Published As

Publication number Publication date
DE2360918C3 (de) 1978-07-20
IL42313A0 (en) 1973-07-30
GB1390683A (en) 1975-04-16
KE2853A (en) 1978-08-04
US3944660A (en) 1976-03-16
NL164472C (nl) 1981-01-15
AU6312673A (en) 1975-06-05
HK41078A (en) 1978-07-28
MY7800368A (en) 1978-12-31
IL42313A (en) 1976-08-31
FR2210399A1 (es) 1974-07-12
FR2210399B1 (es) 1977-01-28
IE38520L (en) 1974-06-18
NL164472B (nl) 1980-08-15
IE38520B1 (en) 1978-03-29
NL7317238A (es) 1974-06-20
BE802700A (fr) 1974-01-23
ZA732438B (en) 1974-01-30
DE2360918B2 (de) 1977-11-10
CA1006091A (en) 1977-03-01
DE2360918A1 (de) 1974-06-27

Similar Documents

Publication Publication Date Title
ES414093A1 (es) Procedimiento para la obtencion de una composicion farmaceutica antiinflamatoria
NL7513370A (nl) Werkwijze voor de bereiding van farmaceutische samenstellingen onder toepassing van l-dopa of verbindingen daarvan.
NL7506848A (nl) Werkwijze ter bereiding van een farmaceutisch preparaat, alsmede werkwijze ter bereiding van een voor een dergelijk preparaat geschikte fysio- logisch werkzame stof.
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
NL189235C (nl) Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
KR830002507A (ko) 옥시테트라사이클린 조성물
JPS51118817A (en) A process for preparing absorbable steroid glycoside pharmaceutical
ES458967A1 (es) Un procedimiento para la preparacion de una composicion de prostaglandina estabilizada.
DE3260227D1 (en) Composition that contains acesulfame, tablets on the basis of this composition and process for their production
HU172372B (hu) Insekticidnye kompozicii soderzhahhie zamehhennye proizvodnye oksi-piridina - zamehhennye slozhnom efirom n,n-dialkilaminokarbamidnojj kisloty i sposob poluchenija aktivnykh agentov
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
IL46543A0 (en) New phenoxyalkyl-carboxylic acid derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
NL7500785A (nl) Werkwijze voor de bereiding van nieuwe carbonzu- ren en derivaten daarvan, werkwijze voor de be- reiding van farmaceutische preparaten die deze nieuwe verbindingen bevatten, alsmede farmaceu- tische preparaten verkregen volgens deze werk- wijze.
ES412146A1 (es) Procedimiento de obtencion de composiciones para reducir elhabito del tabaco.
IL48352A0 (en) New aminoglycoside derivative and its salts,process for preparing them and pharmaceutical compositions
JPS526071A (en) Mercury emission getter material
GB1327560A (en) Effervescent pharmaceutical preparations
JPS5259186A (en) Preparation of 3-cephem compounds by reduction
NL7416691A (nl) Werkwijze voor de bereiding van 17(alpha)-acyloxy-21- oxypregnanen, alsmede farmaceutische pre- en die deze verbindingen als actieve com- ten omvatten.
NL7509032A (nl) Werkwijze ter bereiding van gesubstitueerde 2h- -pyraan-2,6(3h)-dion derivaten, alsmede van far- maceutische preparaten die deze verbindingen als actieve component omvatten.
IL43727A0 (en) New 2,2-dimethyl steroids,process for their preparation and pharmaceutical compositions
NL160800C (nl) Werkwijze voor de bereiding van 1-methyl 3-isopropyl of -isopropenyl 2- gesubstitueerde 1-cyclopentenen, alsmede voor de bereiding van reukstofcomposities, die deze verbindingen bevatten.
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.